Usana Health Sciences (NYSE:USNA) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $0.43 by 116.28 percent. This is a 109.46 percent decrease over earnings of $0.74 per share from the same period last year. The company reported quarterly sales of $223.273 million which missed the analyst consensus estimate of $235.003 million by 4.99 percent. This is a 5.33 percent decrease over sales of $235.848 million the same period last year.